The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Stage

Series A | Alive

About Zhiwei Xinke

Developer of full-automatic marrow karyocyte analysis system. The company's system can classify 40 categories cells. The system is designed to learn and analyze inspection report through deep learning and artificial intelligence (AI), so that can help doctors improve their diagnose efficiency and accuracy.

Zhiwei Xinke Headquarter Location

Haichuang Center, 1288 West Wenyi Road Suite 509-512

Hangzhou, Zhejiang , 310000,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Zhiwei Xinke

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Zhiwei Xinke is included in 5 Expert Collections, including Digital Health.

D

Digital Health

13,075 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

M

Medical Devices

8,448 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

2,707 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

H

Health IT

10,939 items

This collection includes public and private companies, as well as startups, that market software solutions to healthcare provider organizations.

C

Clinical Encounter Tech

623 items

  • Where is Zhiwei Xinke's headquarters?

    Zhiwei Xinke's headquarters is located at Haichuang Center, 1288 West Wenyi Road, Hangzhou.

  • What is Zhiwei Xinke's latest funding round?

    Zhiwei Xinke's latest funding round is Series A.

  • Who are the investors of Zhiwei Xinke?

    Investors of Zhiwei Xinke include Puhua Capital, Yinxinggu Capital and Jiansu.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.